BioSpace News Archive

Pharm Country

Cagent Vascular Raises $11.87M to Fund the Growth and Expansion of the Serranator Family of Percutaneous Transluminal Angioplasty (PTA) Serration Balloon Catheters

Cagent Vascular®announced the completion of $11.87 million in Series B funding.

July 12, 2018
·
3 min read
Business

Medical Marijuana Clinic, CannaMD, Expands to Fort Lauderdale, Miami, and West Palm Beach

CannaMD has tripled in size in less than six months.

July 12, 2018
·
2 min read
Policy

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Acute myeloid leukemia (AML) is one of the most aggressive cancers, with a very low survival rate and few options available for patients who are ineligible for intensive chemotherapy

July 12, 2018
·
14 min read
Policy

Genentech Announces Submission of Supplemental New Drug Application for Venclexta for People With Previously Untreated Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Venclexta represents a potential new way of treating AML, the most common type of aggressive leukemia in adults

July 12, 2018
·
16 min read
Alligator Bioscience AB Interim Report January-June 2018

Positive data for our preclinical projects

July 12, 2018
·
4 min read
Pharm Country

BD Shares Progress towards Achieving 2020 Sustainability Goals

BD (Becton, Dickinson and Company) issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that support the company’s 2020 Sustainability Goals.

July 12, 2018
·
3 min read
Genetown

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-Generation Antibody-Based Therapeutics into the Clinic

Initial programs to focus on immuno-oncology, inflammation and autoimmune disorders

July 12, 2018
·
3 min read
Deals

ViaDerma Provides an Update to Shareholders via a Letter from the CEOThe Company is also in early stage discussions to sell its product on TV

ViaDerma, Inc. is pleased to announce it has posted a letter from President and CEO, Dr. Christopher Otiko on the Company’s website, www.viadermalicensing.com. (Link to CEO Letter)

July 12, 2018
·
1 min read
Business

NanoViricides Provides Update on Recent Events

NanoViricides, Inc. reports that it is financially sound and that its drug candidates in the HerpeCide™ program are moving towards the clinical stage at a reasonable pace.

July 12, 2018
·
5 min read
BioMidwest

NAMSA® Launches “Uniquely IVD” Development Services to Expedite In Vitro Diagnostic Technology Commercialization Efforts for Global Manufacturers

NAMSA® announced the launch of its In Vitro Diagnostic (IVD) development business to provide global manufacturers a proven resource for expedited commercialization outcomes delivered via NAMSA’s “Uniquely IVD” regulatory, quality and clinical research services.

July 12, 2018
·
3 min read